Improving outcomes for patients with hip osteoarthritis: a randomised controlled trial - Hip Injection Trial (HIT)

Keele University0 sites348 target enrollmentAugust 22, 2019

Overview

No summary available.

Registry

who.int

Start Date

August 22, 2019

End Date

TBD

Last Updated

6 years ago

Study Type

Interventional clinical trial of medicinal product

Sponsor

•1\. Male or female aged \= 40 years
•2\. A clinical diagnosis of unilateral or bilateral hip OA, and confirmed on plain radiography within the last 2 years, as made by a trained clinician in the musculoskeletal service
•3\. Moderate to severe current hip pain (a score of 4 or more on a 0\-10 numeric rating scale)
•4\. Symptom duration of episode of at least 6 weeks
•5\. Hip pain occuring on most days of the last month
•6\. Informed written consent provided by the patient
•Are the trial subjects under 18? no
•Number of subjects for this age range: 0
•F.1\.2 Adults (18\-64 years) yes
•F.1\.2\.1 Number of subjects for this age range 116

•Participants with the following characteristics are ineligible for the trial:
•1\. Hip pain due to other disorders (e.g. trochanteric bursitis, avascular necrosis, pain referred from back)
•2\. Intra\-articular corticosteroid injection into the affected hip or ipsilateral trochanteric bursa injection within the proceding 3 months
•3\. Any previous surgery on the affected hip
•4\. Clinical suspicion of local or systemic sepsis or infection
•5\. Current or previous infection of the affected hip
•6\. Significant trauma to the affected hip requiring immobilisation in the previous 3 months
•7\. Unwillingness to undergo study interventions
•8\. Unable to understand and complete self report questionnaires written (or spoken) in English
•9\. Significant illness (known or suspected) including, but not limited to: